Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16804087

Download in:

View as

General Info

PMID
16804087